when was glp-1 discovered Why GLP-1 drugs are changing
Description
Its GLP-1 drug semaglutide failed to treat Alzheimers across two large trials
PMID: 31087391
The new review suggests there is no evidence of harm and some evidence of benefit, but the evidence base remains limited and the drugs remain unapproved for this specific use
10.1002/fsn3.1327 67 KhuntiK.KnightonP.ZaccardiF.BakhaiC.BarronE.HolmanN.et al (2021)
If you plan to stick with compounded semaglutide, consider consulting a new telehealth provider that currently offers compounded semaglutide prescriptions with personalized treatment plans that are not commercially available
